nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—GALR3—retina—malignant glioma	0.104	0.35	CbGeAlD
Ritodrine—GALR3—cerebellum—malignant glioma	0.053	0.179	CbGeAlD
Ritodrine—PGD—retina—malignant glioma	0.0259	0.0874	CbGeAlD
Ritodrine—PGD—telencephalon—malignant glioma	0.0239	0.0804	CbGeAlD
Ritodrine—PGD—medulla oblongata—malignant glioma	0.0187	0.0632	CbGeAlD
Ritodrine—PGD—midbrain—malignant glioma	0.0171	0.0577	CbGeAlD
Ritodrine—PGD—spinal cord—malignant glioma	0.0167	0.0563	CbGeAlD
Ritodrine—PGD—central nervous system—malignant glioma	0.0136	0.0457	CbGeAlD
Ritodrine—PGD—cerebellum—malignant glioma	0.0133	0.0447	CbGeAlD
Ritodrine—PGD—brain—malignant glioma	0.0108	0.0363	CbGeAlD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.0024	0.00341	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HIST1H3B—malignant glioma	0.00236	0.00336	CbGpPWpGaD
Ritodrine—PGD—Disease—JAG2—malignant glioma	0.00236	0.00336	CbGpPWpGaD
Ritodrine—PGD—Metabolism—IDH1—malignant glioma	0.00235	0.00335	CbGpPWpGaD
Ritodrine—PGD—Metabolism—SPHK1—malignant glioma	0.00228	0.00324	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—CXCL8—malignant glioma	0.00226	0.00322	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—MMP3—malignant glioma	0.00226	0.00321	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CYP2C18—malignant glioma	0.00223	0.00317	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—JAG2—malignant glioma	0.00216	0.00307	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00208	0.00296	CbGpPWpGaD
Ritodrine—PGD—Disease—H3F3A—malignant glioma	0.002	0.00284	CbGpPWpGaD
Ritodrine—ADRB2—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.0019	0.00271	CbGpPWpGaD
Ritodrine—PGD—Disease—JAG1—malignant glioma	0.00188	0.00268	CbGpPWpGaD
Ritodrine—PGD—Disease—FBXW7—malignant glioma	0.00185	0.00263	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—CCR4—malignant glioma	0.00183	0.0026	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—H3F3A—malignant glioma	0.00183	0.0026	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—F2—malignant glioma	0.00181	0.00258	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CXCR3—malignant glioma	0.00181	0.00257	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GSTT1—malignant glioma	0.0018	0.00257	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00178	0.00254	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—YWHAE—malignant glioma	0.00176	0.0025	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NTRK2—malignant glioma	0.00176	0.0025	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FLT1—malignant glioma	0.00175	0.00249	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—DUSP6—malignant glioma	0.00174	0.00248	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PIK3CG—malignant glioma	0.00173	0.00247	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—JAG1—malignant glioma	0.00172	0.00245	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NOTCH3—malignant glioma	0.00171	0.00244	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTGS1—malignant glioma	0.00169	0.0024	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FBXW7—malignant glioma	0.00169	0.0024	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—BDKRB2—malignant glioma	0.00165	0.00235	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—F2—malignant glioma	0.00165	0.00234	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00163	0.00232	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AKT2—malignant glioma	0.00159	0.00226	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PIK3CG—malignant glioma	0.00157	0.00224	CbGpPWpGaD
Ritodrine—PGD—Metabolism—BCHE—malignant glioma	0.00157	0.00224	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LATS2—malignant glioma	0.00156	0.00222	CbGpPWpGaD
Ritodrine—PGD—Metabolism—SLC5A5—malignant glioma	0.00155	0.00221	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PTPN11—malignant glioma	0.00155	0.0022	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NOTCH2—malignant glioma	0.00154	0.00219	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PIK3CD—malignant glioma	0.00152	0.00217	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KNG1—malignant glioma	0.0015	0.00214	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00148	0.00211	CbGpPWpGaD
Ritodrine—PGD—Disease—CDKN2B—malignant glioma	0.00145	0.00206	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AKT2—malignant glioma	0.00144	0.00205	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NTRK1—malignant glioma	0.00143	0.00204	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PIK3CD—malignant glioma	0.00138	0.00197	CbGpPWpGaD
Ritodrine—PGD—Disease—HES1—malignant glioma	0.00138	0.00196	CbGpPWpGaD
Ritodrine—PGD—Disease—NCOR1—malignant glioma	0.00137	0.00195	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—CXCR3—malignant glioma	0.00136	0.00193	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MMP3—malignant glioma	0.00133	0.0019	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PIK3CB—malignant glioma	0.00133	0.00189	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CDKN2B—malignant glioma	0.00132	0.00188	CbGpPWpGaD
Ritodrine—PGD—Disease—PDGFRA—malignant glioma	0.00131	0.00187	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTK2—malignant glioma	0.00128	0.00183	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—CXCL8—malignant glioma	0.00128	0.00182	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HES1—malignant glioma	0.00126	0.00179	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NCOR1—malignant glioma	0.00125	0.00178	CbGpPWpGaD
Ritodrine—PGD—Metabolism—GSTP1—malignant glioma	0.00125	0.00178	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—BDKRB2—malignant glioma	0.00124	0.00177	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—RAF1—malignant glioma	0.00124	0.00176	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—IL2—malignant glioma	0.00122	0.00174	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CAT—malignant glioma	0.00122	0.00173	CbGpPWpGaD
Ritodrine—PGD—Disease—TERT—malignant glioma	0.00121	0.00172	CbGpPWpGaD
Ritodrine—PGD—Disease—HLA-A—malignant glioma	0.00121	0.00172	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PIK3CB—malignant glioma	0.00121	0.00172	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PDGFRA—malignant glioma	0.0012	0.00171	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—LATS1—malignant glioma	0.00118	0.00168	CbGpPWpGaD
Ritodrine—PGD—Disease—PDGFB—malignant glioma	0.00118	0.00168	CbGpPWpGaD
Ritodrine—PGD—Disease—FGFR1—malignant glioma	0.00117	0.00167	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SPP1—malignant glioma	0.00116	0.00166	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—CXCL8—malignant glioma	0.00116	0.00165	CbGpPWpGaD
Ritodrine—PGD—Disease—HIF1A—malignant glioma	0.00116	0.00164	CbGpPWpGaD
Ritodrine—PGD—Metabolism—NCOR1—malignant glioma	0.00115	0.00163	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—KNG1—malignant glioma	0.00113	0.00161	CbGpPWpGaD
Ritodrine—PGD—Disease—CAV1—malignant glioma	0.00112	0.00159	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—IL2—malignant glioma	0.00111	0.00158	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TERT—malignant glioma	0.0011	0.00157	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PDGFB—malignant glioma	0.00108	0.00153	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FGFR1—malignant glioma	0.00107	0.00153	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—HIF1A—malignant glioma	0.00106	0.0015	CbGpPWpGaD
Ritodrine—PGD—Disease—BAD—malignant glioma	0.00105	0.0015	CbGpPWpGaD
Ritodrine—PGD—Disease—NOTCH1—malignant glioma	0.00104	0.00148	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CCR4—malignant glioma	0.00103	0.00147	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CAV1—malignant glioma	0.00102	0.00145	CbGpPWpGaD
Ritodrine—PGD—Disease—CD80—malignant glioma	0.00102	0.00145	CbGpPWpGaD
Ritodrine—PGD—Disease—APC—malignant glioma	0.00102	0.00145	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KDR—malignant glioma	0.00101	0.00144	CbGpPWpGaD
Ritodrine—PGD—Disease—EGF—malignant glioma	0.00101	0.00143	CbGpPWpGaD
Ritodrine—PGD—Disease—PTPN11—malignant glioma	0.001	0.00142	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FN1—malignant glioma	0.000972	0.00138	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—F2—malignant glioma	0.000972	0.00138	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—BAD—malignant glioma	0.000961	0.00137	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000959	0.00136	CbGpPWpGaD
Ritodrine—PGD—Disease—BRAF—malignant glioma	0.000957	0.00136	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—NOTCH1—malignant glioma	0.000951	0.00135	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CCR4—malignant glioma	0.000937	0.00133	CbGpPWpGaD
Ritodrine—PGD—Metabolism—CAV1—malignant glioma	0.000936	0.00133	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CD80—malignant glioma	0.000932	0.00133	CbGpPWpGaD
Ritodrine—PGD—Disease—AKT2—malignant glioma	0.000932	0.00133	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CG—malignant glioma	0.00093	0.00132	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—APC—malignant glioma	0.00093	0.00132	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EGF—malignant glioma	0.00092	0.00131	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTPN11—malignant glioma	0.000914	0.0013	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CD—malignant glioma	0.000895	0.00127	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—BRAF—malignant glioma	0.000874	0.00124	CbGpPWpGaD
Ritodrine—PGD—Disease—FGF2—malignant glioma	0.000857	0.00122	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CG—malignant glioma	0.000853	0.00121	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AKT2—malignant glioma	0.000851	0.00121	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—EGFR—malignant glioma	0.000848	0.00121	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PPARG—malignant glioma	0.000823	0.00117	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CD—malignant glioma	0.000818	0.00116	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—PIK3CA—malignant glioma	0.00081	0.00115	CbGpPWpGaD
Ritodrine—PGD—Disease—MDM2—malignant glioma	0.000802	0.00114	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—KRAS—malignant glioma	0.000801	0.00114	CbGpPWpGaD
Ritodrine—PGD—Disease—RAF1—malignant glioma	0.000799	0.00114	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MDK—malignant glioma	0.000799	0.00114	CbGpPWpGaD
Ritodrine—PGD—Disease—ERBB2—malignant glioma	0.000791	0.00113	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—FGF2—malignant glioma	0.000783	0.00111	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CB—malignant glioma	0.00078	0.00111	CbGpPWpGaD
Ritodrine—PGD—Disease—PTGS2—malignant glioma	0.000773	0.0011	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CXCR3—malignant glioma	0.000767	0.00109	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—DTX1—malignant glioma	0.000762	0.00108	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CD—malignant glioma	0.00075	0.00107	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—PIK3CA—malignant glioma	0.000736	0.00105	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MDM2—malignant glioma	0.000733	0.00104	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—RAF1—malignant glioma	0.00073	0.00104	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—F2—malignant glioma	0.00073	0.00104	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—ERBB2—malignant glioma	0.000722	0.00103	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CB—malignant glioma	0.000713	0.00101	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—BDKRB2—malignant glioma	0.000702	0.000998	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CXCR3—malignant glioma	0.000697	0.000991	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CXCL8—malignant glioma	0.000685	0.000975	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000676	0.000961	CbGpPWpGaD
Ritodrine—PGD—Disease—PTEN—malignant glioma	0.000674	0.000959	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AKT1—malignant glioma	0.000662	0.000942	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CASP3—malignant glioma	0.000656	0.000933	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IL2—malignant glioma	0.000655	0.000932	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CB—malignant glioma	0.000653	0.00093	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTGS2—malignant glioma	0.000647	0.000921	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—KNG1—malignant glioma	0.000638	0.000908	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—BDKRB2—malignant glioma	0.000637	0.000907	CbGpPWpGaD
Ritodrine—Bezafibrate—PPARG—malignant glioma	0.000635	1	CrCbGaD
Ritodrine—GALR3—Signaling Pathways—MMP9—malignant glioma	0.00062	0.000882	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PTEN—malignant glioma	0.000616	0.000877	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SUFU—malignant glioma	0.000605	0.000861	CbGpPWpGaD
Ritodrine—PGD—Disease—STAT3—malignant glioma	0.000603	0.000858	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AKT1—malignant glioma	0.000601	0.000855	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HEY2—malignant glioma	0.000598	0.000851	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—GFAP—malignant glioma	0.000584	0.000831	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—KNG1—malignant glioma	0.00058	0.000825	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SPHK1—malignant glioma	0.000565	0.000804	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PTEN—malignant glioma	0.000565	0.000804	CbGpPWpGaD
Ritodrine—PGD—Disease—MYC—malignant glioma	0.00056	0.000797	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—VEGFA—malignant glioma	0.000556	0.000792	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HEY1—malignant glioma	0.000554	0.000788	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CCR4—malignant glioma	0.000554	0.000788	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—STAT3—malignant glioma	0.000551	0.000784	CbGpPWpGaD
Ritodrine—PGD—Disease—EGFR—malignant glioma	0.000548	0.00078	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HIST1H3B—malignant glioma	0.000538	0.000765	CbGpPWpGaD
Ritodrine—PGD—Disease—KRAS—malignant glioma	0.000518	0.000737	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—CXCL8—malignant glioma	0.000514	0.000732	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—MMP3—malignant glioma	0.000514	0.000731	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—MYC—malignant glioma	0.000512	0.000728	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—EGFR—malignant glioma	0.000501	0.000713	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—JAG2—malignant glioma	0.000491	0.000699	CbGpPWpGaD
Ritodrine—PGD—Disease—PIK3CA—malignant glioma	0.000476	0.000677	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—KRAS—malignant glioma	0.000473	0.000673	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PIK3CA—malignant glioma	0.000435	0.000618	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TP53—malignant glioma	0.00042	0.000598	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—H3F3A—malignant glioma	0.000415	0.000591	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—F2—malignant glioma	0.000413	0.000587	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCR3—malignant glioma	0.000411	0.000586	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NTRK2—malignant glioma	0.0004	0.00057	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—YWHAE—malignant glioma	0.0004	0.00057	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FLT1—malignant glioma	0.000399	0.000567	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3CA—malignant glioma	0.000398	0.000567	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—DUSP6—malignant glioma	0.000397	0.000565	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000395	0.000562	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—JAG1—malignant glioma	0.000392	0.000557	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NOTCH3—malignant glioma	0.00039	0.000555	CbGpPWpGaD
Ritodrine—PGD—Disease—AKT1—malignant glioma	0.000389	0.000553	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FBXW7—malignant glioma	0.000384	0.000546	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BDKRB2—malignant glioma	0.000376	0.000536	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—F2—malignant glioma	0.000375	0.000533	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AKT2—malignant glioma	0.000361	0.000514	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CG—malignant glioma	0.000359	0.00051	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AKT1—malignant glioma	0.000355	0.000505	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PTPN11—malignant glioma	0.000352	0.000501	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NOTCH2—malignant glioma	0.00035	0.000498	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000347	0.000494	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KNG1—malignant glioma	0.000342	0.000487	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AKT2—malignant glioma	0.000328	0.000467	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NTRK1—malignant glioma	0.000326	0.000464	CbGpPWpGaD
Ritodrine—PGD—Metabolism—AKT1—malignant glioma	0.000325	0.000463	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CD—malignant glioma	0.000315	0.000449	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MMP3—malignant glioma	0.000303	0.000432	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CB—malignant glioma	0.000303	0.00043	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CDKN2B—malignant glioma	0.000301	0.000428	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTK2—malignant glioma	0.000292	0.000416	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—CXCL8—malignant glioma	0.000291	0.000414	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HES1—malignant glioma	0.000287	0.000408	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NCOR1—malignant glioma	0.000285	0.000406	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—RAF1—malignant glioma	0.000281	0.0004	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—IL2—malignant glioma	0.000278	0.000395	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CB—malignant glioma	0.000275	0.000391	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	0.000273	0.000389	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SPP1—malignant glioma	0.000265	0.000377	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	0.000264	0.000376	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—IL2—malignant glioma	0.000252	0.000359	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TERT—malignant glioma	0.000251	0.000358	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PDGFB—malignant glioma	0.000245	0.000349	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGFR1—malignant glioma	0.000244	0.000347	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—HIF1A—malignant glioma	0.00024	0.000342	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CAV1—malignant glioma	0.000233	0.000331	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KDR—malignant glioma	0.00023	0.000327	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—F2—malignant glioma	0.000221	0.000315	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FN1—malignant glioma	0.000221	0.000315	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BAD—malignant glioma	0.000219	0.000311	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	0.000217	0.000308	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CD80—malignant glioma	0.000212	0.000302	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—APC—malignant glioma	0.000212	0.000301	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	0.000212	0.000301	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EGF—malignant glioma	0.000209	0.000298	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTPN11—malignant glioma	0.000208	0.000296	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—BRAF—malignant glioma	0.000199	0.000283	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKT2—malignant glioma	0.000194	0.000276	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—EGFR—malignant glioma	0.000193	0.000275	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	0.000186	0.000265	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000184	0.000262	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—KRAS—malignant glioma	0.000182	0.000259	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—FGF2—malignant glioma	0.000178	0.000254	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	0.000167	0.000238	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MDM2—malignant glioma	0.000167	0.000237	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—RAF1—malignant glioma	0.000166	0.000237	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—ERBB2—malignant glioma	0.000164	0.000234	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	0.000162	0.000231	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CXCL8—malignant glioma	0.000156	0.000222	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	0.000151	0.000214	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CASP3—malignant glioma	0.000149	0.000212	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IL2—malignant glioma	0.000149	0.000212	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MMP9—malignant glioma	0.000141	0.000201	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PTEN—malignant glioma	0.00014	0.0002	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AKT1—malignant glioma	0.000137	0.000195	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VEGFA—malignant glioma	0.000127	0.00018	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—STAT3—malignant glioma	0.000125	0.000178	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—MYC—malignant glioma	0.000117	0.000166	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—EGFR—malignant glioma	0.000114	0.000162	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—KRAS—malignant glioma	0.000108	0.000153	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	9.89e-05	0.000141	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TP53—malignant glioma	9.57e-05	0.000136	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AKT1—malignant glioma	8.08e-05	0.000115	CbGpPWpGaD
